When your imaging must be precise and reliable, CJ215 delivers.
This next-generation tumour-labelling dye is validated across multiple models ; breast, pancreatic, prostate, colon and fibrosarcoma ; so you can trust your data from the very first experiment.
Wht researchers choose CJ215
High-contrast NIR/SWIR animal imaging, even under ambient light
Specific tumour binding for clear visualisation and accurate quantification
Stable signal up to 168 h, supporting extended in-vivo studies
Whether you’re investigating tumour biology, therapeutic response or multi-modal imaging, CJ215 integrates seamlessly into established workflows, helping you move from experiment to insight faster.
Discover how CJ215 from Proimaging can accelerate your oncology research
Looking beyond tumour models?
Discover advanced tools for super-resolution applications such as STED microscopy and more
Explore their full live-cell imaging portfolio: https://lnkd.in/ecQkdAwh
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
